A common question in today’s market and business environment is whether R&D investment translates into a profitable and marketable solution or product. This question is addressed in a recent Booz & Company survey, which maps the efficiency of R&D investment against the ability of each company to market goods and services.
One of the facts that stand out in the survey is that Apple, one of the main examples of transforming innovative ideas into marketable products, spends roughly 2.2% of sales on R&D, well below the industry average of 6.5%. This is another example of the lack of correlation between investment in R&D and the development of marketable products.
The survey also reveals that companies that engage customers in order to understand their needs and wants and then try to be first in developing new products that respond to those needs, tend to be more effective in their early-stage innovation efforts.
One of the survey’s main conclusions is the notion that the financial crisis did not slow down R&D investment, as companies are keener to generate profit from new products and ideas. However, successful innovation does not appear to necessarily involve new techniques (e.g. social networking and co-creation, cutting edge physics) just the knowledge of what works and what does not really work in the marketplace.
The chart below shows the effectiveness of innovation (measured as a trade-off between idea creation and conversion):
The effectiveness of innovation can also be measured by the amount of innovation pursuers and GDP % of investment in R&D. The chart below shows the tendencies of this indicator for OECD countries.
Finland is the country with the highest number of scientists and engineers and higher percentage of R&D investment. Israel is an interesting case, as the country invests heavily in R&D yet does not need a high number of scientists in order to do so – an example of efficiency. At the other end of the spectrum is Greece, which produces a high number of scientists yet does not invest in R&D.